Header graphic for print
The Healthcare Investor Insights on Issues & Trends that Impact Investments in Healthcare & Life Science Businesses

Healthcare & Life Sciences Private Equity Deal Tracker: Quest Diagnostics to Acquire Solstas Lab Partners for $570 Million

Posted in Healthcare Services Investing

Quest Diagnostics has announced it has entered into a definitive agreement to acquire Solstas Lab Partners Group and its subsidiaries for approximately $570 million.

Solstas, a commercial laboratory company based in Greensboro, N.C., is a portfolio company of Welsh, Carson, Anderson and Stowe. WCAS is a New York-based PE firm specializing in information/business services and healthcare businesses.

Quest, a provider of diagnostic information services headquartered in Madison, N.J., expects to complete the acquisition of Solstas in the first half of 2014.

We use cookies to enhance your experience of our website. By continuing to use this website, you agree to the use of these cookies. For more information and to learn how you can change your cookie settings, please see our policy.

Agree